Barclays reaffirms its 'weight in line' recommendation on Givaudan, with a price target raised from 4070 to 4200 Swiss francs, pointing to a 'solid third quarter, with broad-based volume growth across activities and regions'.

Forecasts of normalized growth in the fourth quarter have somewhat overshadowed the picture, but this was not unexpected", says the broker, who is raising its EPS for 2024 by 2.1% thanks to stronger volume and margin assumptions.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.